Jump Financial, LLC Astria Therapeutics, Inc. Transaction History

Jump Financial, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$8.97 - $12.65 $616,212 - $869,017	-68,697 Closed	0 $0
Q2 2024 Aug 14, 2024	BUY	$8.83 - $13.51 $606,594 - $928,096	68,697 New	68,697 $625,000
Q3 2023 Oct 21, 2024	SELL	$6.89 - $9.86 $370,482 - $530,182	-53,771 Reduced 78.27%	14,926 $111,000
Q3 2023 Nov 07, 2023	BUY	$6.89 - $9.86 $102,840 - $147,170	14,926 New	14,926 $111,000
Q4 2022 Feb 13, 2023	BUY	$7.44 - $14.89 $46,805 - $93,672	6,291 Added 52.43%	18,291 $272,000
Q3 2022 Nov 07, 2022	BUY	$2.97 - $10.34 $35,640 - $124,080	12,000 New	12,000 $108,000

107

48.6M

48K

9.3K

Ticker ATXS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,178,000
Market Cap $145M
Description
Astria Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare and niche allergic, and immunological diseases in the United States. Its lead product candidate is STAR-0215, a monoclonal antibody inhibitor of plasma kallikrein, which is in preclinical development stage...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.